These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8138025)

  • 1. Differential effect of xanthopterin and biopterin on cell growth.
    Rubenstein M; Muchnik S; Garber SL; Arruda JA; Dunea G
    Int J Biochem; 1993 Dec; 25(12):1873-80. PubMed ID: 8138025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pteridines on normal and neoplastic cell lines of Xiphophorus.
    Ritter S; Henze M; Anders F
    Cell Biol Int Rep; 1988 Jun; 12(6):431-42. PubMed ID: 3401938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chain of unexpected discovery: xanthopterin-stimulated renal mitosis.
    Haddow A; Ross WC; Timmis GM
    Perspect Biol Med; 1972; 15(2):177-217. PubMed ID: 4551972
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin, and pterin.
    Rokos H; Rokos K; Frisius H; Kirstaedter HJ
    Clin Chim Acta; 1980 Aug; 105(2):275-86. PubMed ID: 7398095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of xanthopterin and isoxanthopterin in MCF-7 cells.
    Lord JL; de Peyster A; Quintana PJ; Metzger RP
    Cancer Lett; 2005 May; 222(1):119-24. PubMed ID: 15837549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II [3H]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation.
    Markaverich BM; Alejandro MA
    Int J Oncol; 1998 May; 12(5):1127-35. PubMed ID: 9538139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GTP cyclohydrolase I by pterins.
    Shen RS; Alam A; Zhang YX
    Biochim Biophys Acta; 1988 Apr; 965(1):9-15. PubMed ID: 3349105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of xanthopterin and other pteridines on the rate of cell proliferation in tissue cell cultures.
    NORRIS ER; MAJNARICH JJ
    Am J Physiol; 1948 Jun; 153(3):488-91. PubMed ID: 18882185
    [No Abstract]   [Full Text] [Related]  

  • 9. Pterins and the regulation of lymphocyte activation on the mode of xanthopterin action.
    Ziegler I
    Hoppe Seylers Z Physiol Chem; 1984 Jun; 365(6):667-73. PubMed ID: 6207092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-fat diet does not influence the growth of the Dunning R3327-H transplantable prostate adenocarcinoma.
    Schwab ED; Normolle D; Pacis RA; Cho SS; Pienta KJ
    Anticancer Res; 1998; 18(5A):3603-7. PubMed ID: 9858946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of testosterone or xanthopterin to influence the induction of renal neoplasms by lead in rats.
    Roe FJ; Boyland E; Dukes CE; Mitchley BC
    Br J Cancer; 1965 Dec; 19(4):860-6. PubMed ID: 5862663
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
    Jungwirth A; Schally AV; Pinski J; Halmos G; Groot K; Armatis P; Vadillo-Buenfil M
    Br J Cancer; 1997; 75(11):1585-92. PubMed ID: 9184172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
    Humphrey PA; Zhu X; Zarnegar R; Swanson PE; Ratliff TL; Vollmer RT; Day ML
    Am J Pathol; 1995 Aug; 147(2):386-96. PubMed ID: 7639332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic activity of xanthopterin added to p-aminobenzoylglutamic acid in experimental macrocytic anemia of rat.
    TENTORI L; VIVALDI G
    Proc Soc Exp Biol Med; 1951 Nov; 78(2):375-8. PubMed ID: 14911889
    [No Abstract]   [Full Text] [Related]  

  • 16. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
    Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
    Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
    Nguyen NM; Lehr JE; Pienta KJ
    Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the xanthopterin on the experimental wounds of the cornea.
    DE VINCENTIIS M
    Acta Ophthalmol (Copenh); 1959; 37():290-3. PubMed ID: 13855696
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of urokinase production by androgens in human prostate cancer cells: effect on tumor growth and metastases in vivo.
    Xing RH; Rabbani SA
    Endocrinology; 1999 Sep; 140(9):4056-64. PubMed ID: 10465276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.